Not finding it? Sign in to also search OpenAlex live.
-
Successful pharmacological intervention at different levels of the complement system in an in vitro complement fixation model for bullous pemphigoid
Jenny Giang, Martijn B. A. van Doorn, Gilles F.H. Diercks, Santiago Rodrı́guez de Córdoba, Thierry P. P. van den Bosch, Marco W.J. Schreurs, +2 more
3citations -
Circulating levels of endogenous complement inhibitors correlate inversely with complement consumption in systemic lupus erythematosus2024 European Journal of Immunology article Medicine Systemic Lupus Erythematosus Research Open access
Stef van der Meulen, Rory Caitlin Monahan, Kyra A. Gelderman, Cees van Kooten, Y K Onno Teng, Tom W. J. Huizinga, +2 more
3citations -
The role of complement activation in autoimmune liver disease2020 Autoimmunity Reviews article Medicine Liver Diseases and Immunity Open access cited by 1 patent
Maaike Biewenga, Arantza Fariña Sarasqueta, Maarten E. Tushuizen, Eveline S. M. de Jonge‐Muller, Bart van Hoek, Leendert Adrianus Trouw
35citations -
C1q-targeting bispecific antibodies bypass Fc to trigger complement activation and receptor clustering agonism2026 Molecular Immunology article Medicine Monoclonal and Polyclonal Antibodies Research Open access
Douwe J. Dijkstra, Marfa Blanter, Els van der Meijden, Rick J. Groenland, Clifford Rodriguez, Boris Bleijlevens, +2 more
0citations -
Spatial profiling of the spleen in mouse and human myelofibrosis reveals complement-driven immune-stromal interactions as a therapeutic target2026 Cell stem cell article Medicine Myeloproliferative Neoplasms: Diagnosis and Treatment Open access
Bérénice Dugué, Pia Wanner, Mayra L. Ruiz Tejada Segura, Mohamed Saad, Lucas Greven, Katrin Götz, +33 more
2citations -
Fc Galactosylation Promotes Hexamerization of Human IgG1, Leading to Enhanced Classical Complement Activation2021 The Journal of Immunology article Medicine Monoclonal and Polyclonal Antibodies Research Open access cited by 1 patent
Thijs L. J. van Osch, Jan Nouta, Ninotska I. L. Derksen, Gerard van Mierlo, C. Ellen van der Schoot, Manfred Wuhrer, +2 more
88citations -
Association of Histologic Parameters with Outcome in C3 Glomerulopathy and Idiopathic Immunoglobulin-Associated Membranoproliferative Glomerulonephritis2022 Clinical Journal of the American Society of Nephrology article Medicine Renal Diseases and Glomerulopathies Open access cited by 1 patent
Hannah J. Lomax-Browne, Nicholas Medjeral‐Thomas, Sean J. Barbour, Jack Gisby, Heedeok Han, Andrew S. Bomback, +19 more
52citations -
Efficacy and safety of sequential therapy with subcutaneous belimumab and one cycle of rituximab in patients with systemic lupus erythematosus: the phase 3, randomised, placebo-controlled BLISS-BELIEVE study2024 Annals of the Rheumatic Diseases article Medicine Systemic Lupus Erythematosus Research Open access
Cynthia B. Aranow, Cornelia F Allaart, Zahir Amoura, Ian N Bruce, Patricia C. Cagnoli, Walter Winn Chatham, +15 more
55citations -
Proteome Analysis of Glomerular Formalin-Fixed Paraffin Embedded Kidney Samples Distinguishes Diabetic Nephropathy from Controls2021 Journal of the American Society of Nephrology article Medicine Renal Diseases and Glomerulopathies Open access
Sophie I. Nagelkerken, George M. C. Janssen, Kimberley Veraar, Peter A. van Veelen, Hans J. Baelde, Roy Lardenoije, +3 more
0citations -
Comprehensive spatial profiling of the spleen in murine and human myelofibrosis identifies targetable immune-stromal interactions2025 Zenodo (CERN European Organization for Nuclear Research) dataset Medicine Myeloproliferative Neoplasms: Diagnosis and Treatment Open access
Bérénice Dugué, Pia Wanner, Mayra L. Ruiz Tejada Segura, Charles Dussiau, Rebekka K. Schneider
0citations -
Comprehensive spatial profiling of the spleen in murine and human myelofibrosis identifies targetable immune-stromal interactions2025 Zenodo (CERN European Organization for Nuclear Research) dataset Medicine Myeloproliferative Neoplasms: Diagnosis and Treatment Open access
Bérénice Dugué, Wanner Pia, Mayra L. Ruiz Tejada Segura, Charles Dussiau, Rebekka K. Schneider
0citations -
LBP1 Interim results of an open-label, multicentre, Phase 1/2 study to assess YTB323 (rapcabtagene autoleucel), a CAR T-cell therapy, for severe refractory systemic lupus erythematosus
Josefina Cortés Hernández, Pere Barba, Mi Kwon, Julia Weinmann‐Menke, Eva Wagner-Drouet, O. Fischer, +9 more
3citations
22 results